b'A Multi-Omics Approach Demonstrates that Spaceflight Leads to\nLipid Accumulation in Mouse Livers\nAfshin Beheshti, PhD\nBioinformatician at GeneLab\nPrincipal Investigator\nSpace Biosciences Division, KBRWyle\nNASA Ames Research Center, Moffett Field, CA\nAdjunct Assistant Professor at Department of Medicine\nRutgers Robert Wood Johnson Medical School\nVisiting Researcher at Broad Institute\nCambridge, MA\nafshin.beheshti@nasa.gov\nabehesht@broadinstitute.org\n\nNational Aeronautics and\nSpace Administration\n\nHealth Risks On Astronauts in Space\n\nOne thing is always missing:\nLIVER as organ of interest for\nspaceflight related health risks!!\n\nSelect health effects due to space radiation\nexposures.\nFrom: J. Chancellor et al., Space Radiation: The Number One Risk to\nAstronaut Health beyond Low Earth Orbit. Life, 4(3), 491-510;\n\nGeneLab (genelab.nasa.gov)\n\nOverview of the Project\n\nPrevious Study on Liver from STS-135 Mission Revealed Lipid\nAccumulation in the Liver\n\nNon-Alcoholic Fatty Liver Disease (NAFLD)\n\nnon-alcoholic steatohepatitis (NASH)\nImage take from:\nhttps://micellebiopharma.com/nonalcoholic-fatty-liver-disease-andnon-alcoholic-steatohepatitis-sc410/\n\nLipid Accumulation Also Occurs in Livers from More Recent\nMissions on the ISS\n\nGlobal View for Transcriptional Factors with Flight vs Ground in\nthe Liver\n\nGSEA Analysis on STS-135 Liver Samples Reveals Dysregulation\nwith Lipid Related Pathways\n\nGSEA Analysis on RR1 and RR3 Liver Samples Reveals Common\nDysregulation with Lipid Related Pathways\n\nCommon Processes and Pathways for all Datasets\n\n\xe2\x80\xa2 Glucagon (GCG): commonly downregulated across all datasets\nand conditions\n\xe2\x80\xa2 Insulin (INS): commonly upregulated across all datasets.\n\xe2\x80\xa2 GCG and INS are more commonly found to be involved with\npancreatic functions to regulate blood sugar levels\n\xe2\x80\xa2 GCG and INS has also been shown that such signals in the liver\ncan play a role with disease state.\n\xe2\x80\xa2 For example, an upregulation of INS can provide the liver\nwith high blood glucose signals.\n\xe2\x80\xa2 In contrast GCG allows the liver to convert glycogen to\nglucose when the blood sugar levels are low, and thus\ndownregulation of GCG would interrupt such conversion\neventually lowering blood glucose levels\n\nSapceflight Duration Dependent Changes in the Liver\n\xe2\x80\xa2\n\n\xe2\x80\xa2\n\nA set of Pathways Increase with duration in space:\n\xe2\x80\xa2 The majority of these pathways are related to increases in the\nadaptive immune system.\n\xe2\x80\xa2 It has been previously shown that long exposure to the space\nenvironment does indeed activate persistent adaptive immune\nsystem pathways which will have potential to impact spaceflight\nassociated health risks linked to reactivation of latent herpesviruses\nand increased incidence of infectious diseases.\n\xe2\x80\xa2 Oxidation of glucose and adipose tissue development are directly\nimpacted by the adaptive immune system and both have been\npreviously linked with adaptive immune system changes during\nspaceflight.\n\xe2\x80\xa2 Protein folding, translation, and ribosome pathways have been\ndirectly linked to activation of the adaptive immune system.\nThe increase in the fatty acid metabolic process pathways are in\nagreement with our results in the previous sections indicating an increase\nin the lipid accumulation as a function of duration in space\n\nProteomics Demonstrate Dysregulation of Lipid Related Proteins\n\nConclusions\n\nAcknowledgements\nhttps://genelab.nasa.gov/\n\nDeanne Taylor Hossein Fazelinia\n\nGary Hardiman Willian da Silveira\n\n'